Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Sharma Vd is active.

Publication


Featured researches published by Sharma Vd.


Microbial Drug Resistance | 2010

Microarray Analysis of Efflux Pump Genes in Multidrug-Resistant Mycobacterium tuberculosis During Stress Induced by Common Anti-Tuberculous Drugs

Anuj Kumar Gupta; Vishwa Mohan Katoch; Devendra Singh Chauhan; Rahul Sharma; Mradula Singh; Krishnamurthy Venkatesan; Sharma Vd

Treatment of multidrug-resistant tuberculosis has become one of the major problems in public health. Understanding the molecular mechanisms of drug resistance has been central to tuberculosis research in recent times. DNA microarray technology provides the platform to study the genomic variations related to these mechanisms on a comprehensive level. To investigate the role of efflux pumps in drug resistance, we have constructed a custom DNA microarray containing 25 drug efflux pump genes of Mycobacterium tuberculosis (Indian Patent file no. 2071/DEL/2007) and monitored changes in the expression of these genes on exposure of common anti-tuberculous drugs. Expression profiling of efflux pump genes in multidrug-resistant M. tuberculosis isolates showed overexpression of 10 genes following exposure to various anti-tuberculous drugs. Although two of these genes (Rv3065 and Rv2938) have already been reported to be active drug efflux pumps in M. tuberculosis in earlier studies, the increased activities of other eight efflux pump genes (Rv1819, Rv2209, Rv2459, Rv2477c, Rv2688, Rv2846, Rv2994, and Rv3728) have been demonstrated in multidrug-resistant isolates by us for the first time. After confirmation of differential expressions of these genes by real-time reverse transcription polymerase chain reaction, it was observed that a simultaneous overexpression of efflux pump genes Rv2459, Rv3728, and Rv3065 was associated with resistance to the combination of isoniazid and ethambutol, and these drugs, along with streptomycin, were identified to group together, where efflux-mediated drug resistance appears to be important in M. tuberculosis and follows a constant pattern of induction in multidrug-resistant isolates. Isoniazid and ethambutol combination was also found to be affected in 10% (6/60) of the clinical isolates in the presence of carbonyl cyanide m-chloro phenylhydrazone in resazurin microtitre plate assay, supporting the role of efflux pumps in the resistance to these drugs. Overexpression of two of the genes (Rv2477 and Rv2209) has also been observed with ofloxacin stress in M. tuberculosis.


Vaccine | 2008

Potential of Mw as a prophylactic vaccine against pulmonary tuberculosis

Kiran Katoch; Padam Singh; Tulsi Adhikari; S.K. Benara; H.B. Singh; D.S. Chauhan; Sharma Vd; Mallika Lavania; A.S. Sachan; Vishwa Mohan Katoch

Mycobacterium w (Mw), is a cultivable, non-pathogenic mycobacterium and has been tried extensively as an immunomodulator in leprosy. This has been found to be safe and has shown beneficial immunoprophylactic effect in population based, double blind placebo controlled trials in North India. These effects were also observed in the vaccine trials in South India. Keeping in view these beneficial effects and its earlier reported protective effect against tuberculosis in animals, its protective efficacy was evaluated in a rural population of about 28,948 people belonging to 272 villages in Ghatampur, Kanpur (India). The population was vaccinated with two doses (1st dose of 1x10(9) heat killed organisms followed 6 months later with a 2nd dose of 5x10(8) organisms) of Mw 10-13 years ago originally to investigate its effect against leprosy. The vaccine/placebo was given to healthy contacts of leprosy patients who had no evidence of suffering from tuberculosis. Incidence and prevalence of pulmonary tuberculosis in the present study was assessed in a blind manner by an active field survey and also retrospectively by history of anti tuberculosis treatment received by the patient in the intervening period (since vaccination), which was also corroborated by scrutinizing the medical records. Diagnosis was confirmed by standard clinical and bacteriological criteria. A total of 69 patients were diagnosed to be suffering from pulmonary tuberculosis during the survey which included 17 new sputum smear positive cases and 52 previously partially treated but still active pulmonary tuberculosis cases. The difference in the new sputum positive cases between the vaccinated (5/17) and placebo groups (12/17) was significant at 5% level of significance for 1 tailed test (Z>1.64). As 75% (52/69) of the cases had been diagnosed as suffering from pulmonary tuberculosis but had not taken adequate therapy all the cases diagnosed during the intervening period were recorded and re-analysis done. The differences are more significant at 1% level of significance for 1 tail test (Z>2.59) when all cases were analysed as a group. A small proportion 12.85% (total number=3036) of the contacts in the study population had BCG scars. On analysis of results on protection against tuberculosis in this group, BCG did provide protection against tuberculosis (p<0.01). In the placebo group the prevalence of tuberculosis was 1.11% which reduced to 0.70% for those who received Mw vaccine (p<0.01) which further decreased to 0.53% in those who had BCG scars and received Mw. These results thus provide evidence suggesting protective efficacy of Mw against pulmonary tuberculosis and that Mw merits investigation in future prospective immunoprophylactic trials along with other candidates for protection against pulmonary tuberculosis.


International Journal of Systematic and Evolutionary Microbiology | 1996

Determination of mycobacterial phylogeny on the basis of immunological relatedness of superoxide dismutases.

Channappa T. Shivannavar; Katoch Vm; Sharma Vd; M. A Patil; Katoch K; Bharadwaj Vp; Sharma Rk; A. S. Bhatia; B. M. Agrawal

Sixteen strains of cultivable mycobacteria were grown in Sautons medium, and Mycobacterium leprae was purified from armadillo liver. Cell extracts were prepared from log-phase growths of each of the cultivable mycobacterial strains. Superoxide dismutase (SOD) enzyme was purified from all cultivable mycobacterial strains included in the study, and antibodies against purified SOD enzyme were raised in rabbits. Immunological distances (ImDs) between these anti-SOD antibodies and SOD antigens were determined by a previously described immunoprecipitation method and by a recently developed enzyme-linked immunosorbent assay (ELISA) technique. The reciprocal ImDs among mycobacterial strains were constant, reproducible and consistent by these two methods. An evolutionary tree was constructed on the basis of estimated ImDs. Except for M. duvalii and M. terrae, slowly and rapidly growing mycobacterial species appeared to be separately grouped by this analysis. Rapid growers clustered into a group which is near that of some slow-growing mycobacteria. M. avium falls almost in the middle of the evolutionary tree and the position of M. leprae was found to be between those of M. avium and M. bovis BCG. Measurement of immunological relatedness of SODs provides an alternative system with which to study the taxonomical relatedness among mycobacteria.


International Journal of Leprosy and Other Mycobacterial Diseases | 2004

In situ hybridization in the histological diagnosis of early and clinically suspect leprosy.

Mohan Natrajan; Kiran Katoch; Vishwa Mohan Katoch; Sharma Vd; Dharmendra Singh; Devendra Singh Chauhan; Singh Hb

The present study tests the utility of the in situ hybridization procedure for M. leprae rRNA in the histological diagnosis of early leprosy and clinically suspect leprosy, both diagnostically demanding situations. The histological confirmation obtained with routine histopathology (Haematoxylin-Eosin staining for studying morphologic alterations and Fite-Faraco staining for demonstration of acid-fast bacilli) were 32% for early leprosy and 25% for clinically suspect leprosy. With performance of the in situ hybridization on the histologically unconfirmed cases, the positivity rates obtained were 58.8% and 55%, respectively. The results of the study confirm the utility of the procedure in the diagnostically difficult situations of early and suspect leprosy, and it is proposed that the procedure be employed in situations of clinical doubt.


Journal of Global Infectious Diseases | 2012

Similarity in the isolation rate of Mycobacterium tuberculosis for new and treated cases of tuberculosis in sputum specimens preserved under cetylpyridinium chloride

Philip Raj Abraham; Sanjay M. Kasetty; Sharma Vd; Channappa T. Shivannavar

Sir, Isolation of Mycobacterium tuberculosis from biological samples is essential in drug resistance survey and initiating treatment for cases suspected to developed drug resistance. In cases like treatment after default, failure and relapse, it is important for clinicians to know the status of drug resistance to previous treatment before the initiation of alternative anti-TB regimens. In most of the earlier studies, cetylpyridinium chloride (CPC), was used to preserve and transport sputum specimens for mycobacterial culture and this experience has shown good isolation rate of M. tuberculosis.[1-3] In this study, the effect of CPC was studied to determine the isolation rate of M. tuberculosis from three different categories of tuberculosis attending ten designated microscopic centers (DMC) of Gulbarga district.


Indian Journal of Medical Research | 2017

Genetic diversity & drug sensitivity profiles of Mycobacterium tuberculosis isolates from two slums of Jaipur city, Rajasthan, India

Bharti Malhotra; Deepti Dashora; Vipin Kumar; Sumit Goyal; Bhavana Sharma; Madhu Kumar; Kailash Narayan Gupta; Sharma Vd; Devendra Singh Chauhan; Kiran Katoch; Vishwa Mohan Katoch

Background & objectives: Slums are considered as hotspots of tuberculosis (TB). The study of genetic diversity and drug susceptibility profile of Mycobacterium tuberculosis (MTB) will help understand the transmission dynamics and can be used for better prevention and control of the disease. The aim of this study was to determine the drug susceptibility profiles and genetic diversity using the random amplified polymorphic DNA (RAPD) and mycobacterial interspersed repetitive units-variable number of tandem repeats (MIRU VNTR) of MTB isolates from sputum samples of pulmonary TB patients residing in the two slums of Jaipur city in Rajasthan, India. Methods: Sputum samples collected from pulmonary TB patients, their contacts and suspects during 2010-2012 were processed for microscopy and mycobacterial culture. Drug susceptibility testing was done by one per cent indirect proportion method on Lowenstein–Jensen medium for first-line anti-TB drugs rifampicin, isoniazid, ethambutol and streptomycin. MTB DNA was extracted by physicochemical method, and DNA fingerprinting was done by RAPD and MIRU VNTR analysis. Results: Among 175 sputum samples collected, 75 were positive (43.8%) for acid-fast bacilli, 83 for MTB culture and four were contaminated. Fifty two isolates (62.7%) were fully sensitive to four drugs, and five (6%) were multidrug resistant (MDR). RAPD analysis of 81 isolates revealed six clusters containing 23 (28.4%) isolates, and 58 (71.6%) were unique. MIRU VNTR analysis clustered 20 (24.7%) isolates, and 61 (75.3%) were unique. Interpretation & conclusions: About 62.7 per cent isolates from the sputum samples from slum areas were sensitive to four drugs; six per cent of isolates were MDR. Poly-resistance other than MDR was high (16%). About one-fourth isolates were clustered by either method. RAPD was rapid, less expensive but had low reproducibility. MIRU VNTR analysis could identify to greater extent the epidemiological link in the population studied.


Indian Journal of Medical Research | 2008

Isolation of Mycobacterium bovis & M. tuberculosis from cattle of some farms in north India--possible relevance in human health

Srivastava K; Devendra Singh Chauhan; Pushpa Gupta; Singh Hb; Sharma Vd; V.S. Yadav; Sreekumaran; Thakral Ss; Dharamdheeran Js; Nigam P; Prasad Hk; Vishwa Mohan Katoch


Indian Journal of Medical Research | 2006

Applications of real-time PCR technology to mycobacterial research

Deepti Parashar; Devendra Singh Chauhan; Sharma Vd; Vishwa Mohan Katoch


International Journal of Leprosy and Other Mycobacterial Diseases | 1989

Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining.

Katoch Vm; Katoch K; Ramanathan U; Sharma Vd; Channappa T. Shivannavar; Datta Ak; Bharadwaj Vp


Indian Journal of Medical Research | 2004

Correlation of mutations detected by INNO-LiPA with levels of rifampicin resistance in Mycobacterium tuberculosis

Srivastava K; Ram Das; Jakhmola P; Pushpa Gupta; Devendra Singh Chauhan; Sharma Vd; Singh Hb; Sachan As; Katoch Vm

Collaboration


Dive into the Sharma Vd's collaboration.

Top Co-Authors

Avatar

Katoch Vm

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Devendra Singh Chauhan

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Vishwa Mohan Katoch

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Kiran Katoch

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Singh Hb

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Mohan Natrajan

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Ram Das

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Srivastava K

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Pushpa Gupta

Indian Council of Medical Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge